Factor V leiden mutation: An unrecognized cause of hemiplegic cerebral palsy, neonatal stroke, and placental thrombosis

被引:105
作者
Thorarensen, O
Ryan, S
Hunter, J
Younkin, DP
机构
[1] CHILDRENS HOSP PHILADELPHIA,DIV NEUROL,PHILADELPHIA,PA 19104
[2] CHILDRENS HOSP PHILADELPHIA,DIV NEURORADIOL,PHILADELPHIA,PA 19104
[3] UNIV PENN,DEPT NEUROL,PHILADELPHIA,PA 19104
[4] UNIV PENN,DEPT PEDIAT,PHILADELPHIA,PA 19104
[5] UNIV PENN,DEPT RADIOL,PHILADELPHIA,PA 19104
关键词
D O I
10.1002/ana.410420316
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Activated protein C resistance caused by an Arg(506)Gln mutation in the factor V gene (factor V Leiden mutation) is the most common cause of familial thrombosis. This mutation is associated with arterial and, venous thromboembolic disease in neonates, infants, and children, but is not a significant risk factor for ischemic stroke in adults. We report on 3 babies with different neonatal cerebrovascular disorders including ischemic infarction and hemorrhagic stroke who are heterozygous for factor V Leiden mutation. One infant had multiple thrombi in the fetal placental vasculature. This is the first reported association between hemiplegic cerebral palsy, placenta thrombosis, and factor V Leiden mutation, We suspect that activated protein C resistance may be an important cause of in utero cerebrovascular disease and hemiplegic cerebral palsy.
引用
收藏
页码:372 / 375
页数:4
相关论文
共 20 条
[1]  
ANDREW M, 1995, THROMB HAEMOSTASIS, V74, P415
[2]   MUTATION IN BLOOD-COAGULATION FACTOR-V ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C [J].
BERTINA, RM ;
KOELEMAN, BPC ;
KOSTER, T ;
ROSENDAAL, FR ;
DIRVEN, RJ ;
DERONDE, H ;
VANDERVELDEN, PA ;
REITSMA, PH .
NATURE, 1994, 369 (6475) :64-67
[3]   Arg(506)-Gln mutation in factor V and risk of thrombosis during pregnancy [J].
Bokarewa, MI ;
Bremme, K ;
Blomback, M .
BRITISH JOURNAL OF HAEMATOLOGY, 1996, 92 (02) :473-478
[4]   FAMILIAL THROMBOPHILIA DUE TO A PREVIOUSLY UNRECOGNIZED MECHANISM CHARACTERIZED BY POOR ANTICOAGULANT RESPONSE TO ACTIVATED PROTEIN-C - PREDICTION OF A COFACTOR TO ACTIVATED PROTEIN-C [J].
DAHLBACK, B ;
CARLSSON, M ;
SVENSSON, PJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (03) :1004-1008
[5]   PHYSIOLOGICAL ANTICOAGULATION - RESISTANCE TO ACTIVATED PROTEIN-C AND VENOUS THROMBOEMBOLISM [J].
DAHLBACK, B .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (03) :923-927
[6]   Activated protein C resistance in childhood stroke [J].
Ganesan, V ;
Kelsey, H ;
Cookson, J ;
Osborn, A ;
Kirkham, FJ .
LANCET, 1996, 347 (8996) :260-260
[7]   SELECTED VASCULAR-LESIONS OF THE PLACENTA [J].
GERSELL, DJ .
CLINICS IN LABORATORY MEDICINE, 1995, 15 (03) :611-629
[8]   THE PREVALENCE OF POOR ANTICOAGULANT RESPONSE TO ACTIVATED PROTEIN-C (APC RESISTANCE) AMONG PATIENTS SUFFERING FROM STROKE OR VENOUS THROMBOSIS AND AMONG HEALTHY-SUBJECTS [J].
HALBMAYER, WM ;
HAUSHOFER, A ;
SCHON, R ;
FISCHER, M .
BLOOD COAGULATION & FIBRINOLYSIS, 1994, 5 (01) :51-57
[9]  
LALOUSCHEK W, 1995, STROKE, V26, P1963
[10]   Coexistence of hereditary homocystinuria and Factor V Leiden - Effect on thrombosis [J].
Mandel, H ;
Brenner, B ;
Berant, M ;
Rosenberg, N ;
Lanir, N ;
Jakobs, C ;
Fowler, B ;
Seligsohn, U .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (12) :763-768